Fit for purpose high‐throughput absolute quantitation of chimeric aducanumab in mouse cortex and plasma
Although unique peptides will vary, we anticipate this general workflow will allow for quantitation of AD focused biotherapeutics. As part of the open science framework, this methodology will be made available to the broader research community to facilitate broad application.
Authors
- Diogo Francisco da Silva dos Santos (ORCID: https://orcid.org/0000-0003-3306-2147)
- Emma H. Doud (ORCID: https://orcid.org/0000-0003-0049-0073)
- Stacey J. Sukoff Rizzo (ORCID: https://orcid.org/0000-0002-1460-8127)
- Amber L. Mosley (ORCID: https://orcid.org/0000-0001-5822-2894)
- Sara K. Quinney (ORCID: https://orcid.org/0000-0002-6554-0695)
- Paul R. Territo (ORCID: https://orcid.org/0000-0003-0460-332X)
- Kathryn A. Haynes
Institutions
- University of Pittsburgh (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.093048
- Primary Topic
- Medicinal Plants and Neuroprotection
- Type
- article
- Field-Weighted Citation Impact
- 0.00